0001768185-19-000005.txt : 20190829 0001768185-19-000005.hdr.sgml : 20190829 20190829141139 ACCESSION NUMBER: 0001768185-19-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190829 DATE AS OF CHANGE: 20190829 EFFECTIVENESS DATE: 20190829 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chinook Therapeutics U.S., Inc. CENTRAL INDEX KEY: 0001768185 IRS NUMBER: 832535029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-347663 FILM NUMBER: 191065621 BUSINESS ADDRESS: STREET 1: 1600 FAIRVIEW AVE. E. CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 604-343-1552 MAIL ADDRESS: STREET 1: 1600 FAIRVIEW AVE. E. CITY: SEATTLE STATE: WA ZIP: 98102 D 1 primary_doc.xml X0708 D LIVE 0001768185 Chinook Therapeutics U.S., Inc. 1600 Fairview Ave. E. Seattle WA WASHINGTON 98102 6043431552 DELAWARE None None Corporation true 2018 Eric Dobmeier c/o Chinook Therapeutics U.S., Inc. 1600 Fairview Ave. E. Seattle WA WASHINGTON 98102 Executive Officer Director Srini Akkaraju c/o Chinook Therapeutics U.S., Inc. 1600 Fairview Ave. E. Seattle WA WASHINGTON 98102 Director Jeremy Caldwell c/o Chinook Therapeutics U.S., Inc. 1600 Fairview Ave. E. Seattle WA WASHINGTON 98102 Director Jerel Davis c/o Chinook Therapeutics U.S., Inc. 1600 Fairview Ave. E. Seattle WA WASHINGTON 98102 Director Sam Hall c/o Chinook Therapeutics U.S., Inc. 1600 Fairview Ave. E. Seattle WA WASHINGTON 98102 Director Other Technology Decline to Disclose 06b false 2019-02-06 false true false 0 65000000 65000000 0 false 5 0 0 0 false Chinook Therapeutics U.S., Inc. /s/ ERIC DOBMEIER Eric Dobmeier President and Chief Executive Officer 2019-08-29